PLANTATION, Fla.–(BUSINESS WIRE)–DentalPlans.com shares top eye safety tips for workers across the country in honor of Workplace Eye Wellness Month.
Author: Business Wire
VisionCare, Inc. Announces Regulatory Approval of the CentraSight Treatment Program in Australia
SARATOGA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank"gt;#AMDlt;/agt;–VisionCare, Inc. announced that the Australian Department of Health Therapeutic Goods Administra…
Global Amblyopia Clinical Trials Review, H2, 2018 Featuring Herantis Pharma & Santen Pharmaceutical – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Amblyopia Global Clinical Trials Review, H2, 2018″ clinical trials has been added to ResearchAndMarkets.com’s offering. Amblyopia Global Clinical Trials Review, H2, 2018” provides an overview of Amblyopia clinical trials scenario. This report provides top line data relating to the clinical trials on Amblyopia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease
Children’s Hospital Los Angeles Receives $1.6M Grant to Study Retinoblastoma
LOS ANGELES–(BUSINESS WIRE)–Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age and accounts for approximately 4% of childhood cancers. If not diagnosed early, retinoblastoma may result in loss of one or both …
BioTime to Present at Oppenheimer & Co. 29th Annual Healthcare Conference on March 20, 2019
ALAMEDA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank"gt;$BTXlt;/agt; lt;a href="https://twitter.com/hashtag/AMD?src=hash" target=&quo…
Aerpio Pharmaceuticals Announces Results From TIME-2b Study of AKB-9778 in Diabetic Retinopathy
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced top-line results from the Compa…
Acucela Signs Agreement to Develop a Compact OCT for NASA’s Deep Space Missions
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that the company signed the agreement with the Translationa…
GenSight Biologics annonce la présentation des résultats à 72 semaines de l’étude clinique de Phase III REVERSE avec GS010 au Congrès 2019 du NANOS
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée à la découverte et au développement de thérapies géniques innovantes pour le traitemen…
GenSight Biologics Announces Presentation of 72-Week Data From the REVERSE Phase III Trial of GS010 at the 45th Annual Meeting of NANOS
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative disease…
Pivotal Trial Results for Glaukos’ iStent inject® Published in Leading Ophthalmic Journal
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
BioTime Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
ALAMEDA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank"gt;$BTXlt;/agt; lt;a href="https://twitter.com/hashtag/AMD?src=hash" target=&quo…
Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that Kourous A. Rezaei, M.D., will present an overview of the Company at the ARM 7th Annual Cell and Gene Therapy Investor Day.
Visioneering Technologies Accelerates UK and ANZ Market Entries with Simultaneous Marketing Campaigns
BIRMINGHAM, United Kingdom & SYDNEY & AUCKLAND, New Zealand–(BUSINESS WIRE)–Visioneering Technologies, Inc. (ASX: VTI): Highlights Visioneering has entered its next phase of international expansion with simultaneous marketing launches in the …
Glaukos Technologies Featured in Numerous Presentations at 2019 American Glaucoma Society Meeting
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision…
Compulink Previews New User Interface for its Ophthalmology SMART EHR at AGS 2019
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink previews new User Interface for its Ophthalmology SMART EHR at AGS 2019.
International Glaucoma Study Confirms Long-term Efficacy and Safety Profile of Glaukos iStent® Implantation in Combination with Cataract Surgery
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, announces a strategic shift in its U.S. commercial…
Empire Eye and Laser Center Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts
BAKERSFIELD, Calif.–(BUSINESS WIRE)–Daniel H. Chang, M.D. at Empire Eye and Laser Center in Bakersfield, Calif., is participating in the AcuFocus IC-8 clinical study for cataracts.
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Deliv…